Terms: = Head and neck cancer AND FGFR1, CEK, 2260, ENSG00000077782, P11362, FLT2, CD331, H3, HBGFR, FGFBR, H5, KAL2, H2, BFGFR, N-SAM, H4
633 results:
1. Potential drug targets for tumors identified through Mendelian randomization analysis.
Song N; Shi P; Cui K; Zeng L; Wang Z; Di W; Li J; Fan Y; Li Z; Zhang J; Su W; Wang H
Sci Rep; 2024 May; 14(1):11370. PubMed ID: 38762700
[TBL] [Abstract] [Full Text] [Related]
2. CD276 regulates the immune escape of esophageal squamous cell carcinoma through CXCL1-CXCR2 induced NETs.
Xiong G; Chen Z; Liu Q; Peng F; Zhang C; Cheng M; Ling R; Chen S; Liang Y; Chen D; Zhou Q
J Immunother Cancer; 2024 May; 12(5):. PubMed ID: 38724465
[TBL] [Abstract] [Full Text] [Related]
3. Preclinical evaluation of two phylogenetically distant arenavirus vectors for the development of novel immunotherapeutic combination strategies for cancer treatment.
Raguz J; Pinto C; Pölzlbauer T; Habbeddine M; Rosskopf S; Strauß J; Just V; Schmidt S; Bidet Huang K; Stemeseder F; Schippers T; Stewart E; Jez J; Berraondo P; Orlinger KK; Lauterbach H
J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38631709
[TBL] [Abstract] [Full Text] [Related]
4. Reprogramming Chromosome Ends by Functional Histone Acetylation.
Meltzer WA; Gupta A; Lin PN; Brown RA; Benyamien-Roufaeil DS; Khatri R; Mahurkar AA; Song Y; Taylor RJ; Zalzman M
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612707
[TBL] [Abstract] [Full Text] [Related]
5. LymphoDose: a lymphocyte dose estimation framework-application to brain radiotherapy.
de Kermenguy F; Benzazon N; Maury P; Vauclin R; M'hamdi M; Cifliku V; Limkin E; Diallo I; Morel D; Milewski C; Clémenson C; Mondini M; Deutsch E; Robert C
Phys Med Biol; 2024 Apr; 69(10):. PubMed ID: 38593817
[No Abstract] [Full Text] [Related]
6. Lipid droplets-related Perilipin-3: potential immune checkpoint and oncogene in oral squamous cell carcinoma.
He Y; Liu L; Dong Y; Zhang X; Song Y; Jing Y; Ni Y; Wang Y; Wang Z; Ding L
Cancer Immunol Immunother; 2024 Mar; 73(5):78. PubMed ID: 38554152
[TBL] [Abstract] [Full Text] [Related]
7. MiR-2110 induced by chemically synthesized cinobufagin functions as a tumor-metastatic suppressor via targeting fgfr1 to reduce PTEN ubiquitination degradation in nasopharyngeal carcinoma.
Fang S; Peng L; Zhang M; Hou R; Deng X; Li X; Xin J; Peng L; Liu Z; Liu Y; Xie Y; Zhou B; Fang W; Liu Z; Cheng C
Environ Toxicol; 2024 Jun; 39(6):3548-3562. PubMed ID: 38477013
[TBL] [Abstract] [Full Text] [Related]
8. BRG1 mediates epigenetic regulation of TNFα-induced CCL2 expression in oral tongue squamous cell carcinoma cells.
Xu M; Lu X; Zhu F; Sun X; Yao H; Zhang J; Chen W; Zhu H; Liu F; Shi SL; Deng X
J Cell Biochem; 2024 Apr; 125(4):e30535. PubMed ID: 38348687
[TBL] [Abstract] [Full Text] [Related]
9. Epigenetics in the diagnosis and prognosis of head and neck cancer: A systematic review.
Lim I; Tan J; Alam A; Idrees M; Brenan PA; Coletta RD; Kujan O
J Oral Pathol Med; 2024 Feb; 53(2):90-106. PubMed ID: 38316046
[TBL] [Abstract] [Full Text] [Related]
10. Methylation of histone H3 lysine 36 is a barrier for therapeutic interventions of head and neck squamous cell carcinoma.
Caeiro LD; Nakata Y; Borges RL; Zha M; Garcia-Martinez L; Bañuelos CP; Stransky S; Liu T; Chan HL; Brabson J; Domínguez D; Zhang Y; Lewis PW; Aznar Benitah S; Cimmino L; Bilbao D; Sidoli S; Wang Z; Verdun RE; Morey L
Genes Dev; 2024 Feb; 38(1-2):46-69. PubMed ID: 38286657
[TBL] [Abstract] [Full Text] [Related]
11. A novel Fc-enhanced humanized monoclonal antibody targeting B7-H3 suppresses the growth of ESCC.
Wu H; Liu C; Yuan Q; Qiao Y; Ding Y; Duan L; Li W; Zhang M; Zhang X; Jiang Y; Lu J; Dong Z; Wang T; Liu K; Zhao J
Oncoimmunology; 2023; 12(1):2282250. PubMed ID: 38126034
[TBL] [Abstract] [Full Text] [Related]
12. Analysis of B7-H4 Expression Across Salivary Gland Carcinomas Reveals Adenoid Cystic Carcinoma-Specific Prognostic Relevance.
Siqueira JM; Mitani Y; Hoff CO; Bonini F; Guimaraes de Sousa L; Marques-Piubelli ML; Purushothaman A; Mitani M; Dai H; Lin SY; Spiotto MT; Hanna EY; McGrail DJ; El-Naggar AK; Ferrarotto R
Mod Pathol; 2024 Jan; 37(1):100371. PubMed ID: 38015043
[TBL] [Abstract] [Full Text] [Related]
13. fgfr1/2/3-rearranged carcinoma of the head and neck: expanded histological spectrum crossing path with high-risk HPV in the sinonasal tract.
Chu YH; Mullaney K; DiNapoli SE; Cohen MA; Xu B; Ghossein R; Katabi N; Dogan S
Histopathology; 2024 Mar; 84(4):589-600. PubMed ID: 38010295
[TBL] [Abstract] [Full Text] [Related]
14. Elevation of H3K27me3 level contributes to the radioresistance of nasopharyngeal carcinoma by inhibiting OAS1 expression.
Zhou Y; Xiao Y; Liu H; Chen Q; Zhu L; Zeng L; Liu X; Pan Y; Zhang J; Fu J; Shao C
Am J Physiol Cell Physiol; 2024 Jan; 326(1):C60-C73. PubMed ID: 38009194
[TBL] [Abstract] [Full Text] [Related]
15. Employing Noble Metal-Porphyrins to Engineer Robust and Highly Active Single-Atom Nanozymes for Targeted Catalytic Therapy in Nasopharyngeal Carcinoma.
Wang D; Wang J; Gao XJ; Ding H; Yang M; He Z; Xie J; Zhang Z; Huang H; Nie G; Yan X; Fan K
Adv Mater; 2024 Feb; 36(7):e2310033. PubMed ID: 37994246
[TBL] [Abstract] [Full Text] [Related]
16. KIFC1 promotes proliferation and pseudo-bipolar division of ESCC through the transportation of Aurora B kinase.
Du B; Wei L; Wang J; Li Y; Huo J; Wang J; Wang P
Aging (Albany NY); 2023 Nov; 15(21):12633-12650. PubMed ID: 37955677
[TBL] [Abstract] [Full Text] [Related]
17. B7H3 targeting gold nanocage pH-sensitive conjugates for precise and synergistic chemo-photothermal therapy against NSCLC.
Chen B; Zheng K; Fang S; Huang K; Chu C; Zhuang J; Lin J; Li S; Yao H; Liu A; Liu G; Lin J; Lin X
J Nanobiotechnology; 2023 Oct; 21(1):378. PubMed ID: 37848956
[TBL] [Abstract] [Full Text] [Related]
18. Multi-kinase compensation rescues EGFR knockout in a cell line model of head and neck squamous cell carcinoma.
Ludwig ML; Michmerhuizen NL; Wang J; Birkeland AC; Majchrowski BK; Nimmagadda S; Zhai J; Bhangale A; Kulkarni A; Jiang H; Swiecicki PL; Brenner JC
Arch Oral Biol; 2023 Dec; 156():105822. PubMed ID: 37844343
[TBL] [Abstract] [Full Text] [Related]
19. Combination therapy with WEE1 inhibition and trifluridine/tipiracil against esophageal squamous cell carcinoma.
Nguyen Vu TH; Kikuchi O; Ohashi S; Saito T; Ida T; Nakai Y; Cao Y; Yamamoto Y; Kondo Y; Mitani Y; Kataoka S; Kondo T; Katada C; Yamada A; Matsubara J; Muto M
Cancer Sci; 2023 Dec; 114(12):4664-4676. PubMed ID: 37724648
[TBL] [Abstract] [Full Text] [Related]
20. Neutrophil extracellular traps and neutrophil-related mediators in human thyroid cancer.
Modestino L; Cristinziano L; Poto R; Ventrici A; Trocchia M; Ferrari SM; Fallahi P; Paparo SR; Marone G; Antonelli A; Varricchi G; Galdiero MR
Front Immunol; 2023; 14():1167404. PubMed ID: 37705974
[TBL] [Abstract] [Full Text] [Related]
[Next]
